Catalio Capital Management, LP

Position in JNJ — Johnson & Johnson

CIK 1958125 NEW YORK, NY

Position in JNJ

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$35,288,115

+$10,280,277 QoQ

Shares Held

138,946

+15.0% QoQ

Ownership

0.006%

of shares outstanding

% of Portfolio

6.63%

of 13F equity value

Holder Rank

#544

of 4,676 holders

Holding Since

Dec 2025

2 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Catalio Capital Management, LP holds $93,107,426 across 3 Drug Manufacturers - General names. JNJ ranks #1 (37.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson This page	138,946	$35,288,115
2	GILD	Gilead Sciences, Inc.	269,309	$34,024,499
3	BMY	Bristol Myers Squibb Co	412,961	$23,794,812

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$35,288,115	138,946	+15.0%	Shares	Sole	2026-08-14
2025-12-31	$25,007,838	120,840	—	Shares	Sole	2026-02-17
No filing history on record for this holder in this stock.